COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
15/05/2024
Named in Honour of the late Dr. Greg Schultz, Former Professor Emeritus at the University of Florida and Chief Science Officer of Kane Biotech WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX [...]
Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
15/05/2024
JERUSALEM, May 15, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today announced the [...]
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
15/05/2024
First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD) 1 New research on Erosive gastroesophageal reflux disease (GERD) demonstrating high health [...]
Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing
15/05/2024
Gaining operating efficiency through transition to an internal environmental monitoring team DURHAM, N.C., May 15, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) , (“Scorpius” or the “Company”), [...]
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
15/05/2024
NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today [...]
PharmaTher’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
15/05/2024
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a [...]
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
15/05/2024
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is commercializing its [...]
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
15/05/2024
— Received Rare Pediatric Disease and Orphan Drug Designation for Duchenne muscular dystrophy (Duchenne) gene therapy candidate SGT-003 with patient dosing in Phase 1/2 trial expected Q2 2024 — — Company entered into [...]
Major shareholder announcement – BlackRock, Inc.
15/05/2024
ANNOUNCEMENT NO. 266 Major shareholder announcement Major shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec [...]
Brand New Technology “LPA Synapse” by LQpay Delivers Reliable, Workflow-Integrated Payments for Dental Practices
15/05/2024
FORT LAUDERDALE, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- LQpay , the leading end-to-end patient payments provider, proudly launches LPA Synapse. Building upon the Company’s existing AI and automation technology and [...]
Philips announces exchange ratio for 2023 dividend
15/05/2024
May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. [...]
Posting of Annual Report & Notice of AGM - Total Voting Rights
15/05/2024
May 15, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Total Voting Rights Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical [...]
VIRBAC: Communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale mixte ordinaire et extraordinaire
15/05/2024
Les actionnaires de la société VIRBAC sont avisés qu’une assemblée générale mixte ordinaire et extraordinaire se tiendra le vendredi 21 juin 2024 à 9 heures , dans les bâtiments de VIRBAC direction, 13ème rue L.I.D., [...]
Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer
15/05/2024
More than half of all U.S. cervical cancer patients are underscreened 1 , which makes reducing barriers to sample collection and increasing access to screenings crucial to ultimately helping eliminate this deadly [...]
Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024
15/05/2024
Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024 Halle (Saale) / Munich, Germany, May 15, 2024 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7 [...]
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
15/05/2024
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF BONDHOLDERS. IF BONDHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD SEEK THEIR OWN FINANCIAL AND LEGAL ADVICE IMMEDIATELY FROM [...]
IHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre
15/05/2024
Mount Elizabeth Novena Hospital (MNH) Singapore is the first private hospital in the region to offer proton therapy; kicked off treatment for first patient on 10 May 2023. Centre has already treated more than 100 [...]
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
15/05/2024
TOKYO and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: [...]
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
15/05/2024
Pain Relief Resulted in Improved Objective Measure of Walking Ability at End of Treatment CLEVELAND, May 14, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a multicenter double-blind randomized, [...]

Pages